Recurrence: all 3,523 studies
Page 7 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.
- Sirolimus in the Treatment of Refractory/Relapsed wAIHARecruitingNCT05925023Not applicable
- A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT05924750Phase 1
- Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple MyelomaRecruitingNCT05922501Phase 2
- A Study of QLS32015 in Patients With Recurrent or Refractory Multiple MyelomaRecruitingNCT05920876Phase 1
- Accelerated Intermittent Theta-Burst Stimulation Ameliorate Major Depressive Disorder by Regulating CAMKII PathwayRecruitingNCT05913960Not applicable
- YTS104 Cell Injection for the Treatment of Relapsed or Refractory Multiple MyelomaRecruitingNCT05913804Phase 1
- Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or AblationNot yet recruitingNCT05910970Phase 3
- Perioperative Treatment With Tranexamic Acid in MelanomaRecruitingNCT05899465Phase 3
- SHR1701 Alone or in Combination With SHR2554 in Relapsed or Refractory Classical Hodgkin LymphomaRecruitingNCT05896046Phase 1/2
- HPV-T in HPV-16 Positive Recurrent or Metastatic Solid TumorsRecruitingNCT05895370Phase 1
- Establishing Multimodal Brain Biomarkers for Treatment Selection in DepressionRecruitingNCT05892744Phase 4
- "Comparative Evaluation of 3 Dimensional Changes of Dentition in Post Orthodontic Patients With Immediate vs Delayed (Post 24 Hours) Retainer DeliveryRecruitingNCT05879601Not applicable
- : "Comparative Evaluation of 3 Dimensional Changes of Dentition in Post Orthodontic Patients With Immediate vs Delayed (Post 3 Days) Retainer DeliveryRecruitingNCT05879588Not applicable
- HOPE to Reduce Tumour Recurrence After LT In Patients With HCCNot yet recruitingNCT05876052Not applicable
- uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With JelmytoRecruitingNCT05874921
- Imaging Features for the Risks for Recurrence After Stereotactic Radiosurgery in Brain MetastasisRecruitingNCT05868928
- Onlay Synthetic Bioabsorbable Mesh Herniorrhaphy Versus Herniorrhaphy Only in the Primary Treatment of Large Hiatal HerniaRecruitingNCT05867225Not applicable
- COLLISION RELAPSE TrialRecruitingNCT05861505Phase 3
- PREventing Second Cancers With DOSTARlimabRecruitingNCT05855811Phase 2
- Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell LymphomaRecruitingNCT05852717Phase 2
- Rituximab in the First Episode of Paediatric Nephrotic SyndromeNot yet recruitingNCT05850546Phase 3
- MyBack - A Behavior Change Informed Exercise Program to Prevent Low Back Pain RecurrencesRecruitingNCT05841732Not applicable
- Evaluation of Sleep Changes in Inflammatory Bowel Diseases (IBD) Patients.RecruitingNCT05835973Not applicable
- Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)RecruitingNCT05833724Phase 2
- Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell LymphomaRecruitingNCT05826535Phase 1/2
- Decitabine and Anti-PD-1 in R/R DLBCLRecruitingNCT05816746Phase 2
- A Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or Refractory B-cell LymphomaNot yet recruitingNCT05814848Phase 4
- Single-Dose Intravesical Chemotherapy After Diagnostic URSNot yet recruitingNCT05810623Phase 3
- Re-irradiation Therapy of Locally Recurrent Rectal Cancer With Carbon IonNot yet recruitingNCT05807984Phase 2
- Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell LymphomaRecruitingNCT05806580Phase 4
- Cellvizio to Evaluate Margins in Crohn's Ileal DiseaseRecruitingNCT05805020Not applicable
- A Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients With Relapsed/Refractory Large B-Cell LymphomaRecruitingNCT05800977Phase 1/2
- Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory LymphomaRecruitingNCT05798897Phase 1
- A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical CancerRecruitingNCT05798819Phase 3
- Treatment Strategies for IgG4-RD Patients With Superficial Organ InvolvementRecruitingNCT05789030Not applicable
- Treatment Strategies for IgG4-RD Patients With Internal Organ InvolvementRecruitingNCT05789017Not applicable
- A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell MalignanciesRecruitingNCT05780034Phase 1
- Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHLNot yet recruitingNCT05779930Early Phase 1
- Partial Breast Re-irradiation in Women in Women with Locally Recurrent Breast Cancer Previously Treated with Conservative Surgery and Whole Breast IrradiationRecruitingNCT05772390Phase 2
- Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's LymphomaRecruitingNCT05768529Phase 1/2
- Effects of Mindfulness Meditation in Virtual Reality on Craving and Smoking CessationRecruitingNCT05766553Not applicable
- A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL PatientsRecruitingNCT05758610Phase 1
- Prolgolimab Monotherapy or in Combination With Bendamustine for r/r Classical Hodgkin LymphomaRecruitingNCT05757466Phase 2
- The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute LeukaemiasRecruitingNCT05756322Phase 1/2
- The HELPP Score: A Pretreatment Score to Predict Survival in Pancreatic CancerRecruitingNCT05752812
- HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesRecruitingNCT05751044Phase 1/2
- A Study of ADCLEC.syn1 in People With Acute Myeloid LeukemiaRecruitingNCT05748197Phase 1
- HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesRecruitingNCT05745714Phase 1/2
- SBRT Combined With AK104 to Treatment Relapsed or Metastatic ESCCNot yet recruitingNCT05732662Phase 2
- CD19-targeted CAR T Cells for Patients With Relapsed or Refractory in B-cell Acute Lymphoblastic LeukemiaRecruitingNCT05727683Phase 1
- Predictors of Disease Recurrence After Curative Surgery for Stage I Colon CancerRecruitingNCT05726188
- Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid LeukemiaRecruitingNCT05726110Phase 3
- Increasing Smoking Cessation Success Through Sleep-amplified Memory ConsolidationRecruitingNCT05726045Not applicable
- Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)Not yet recruitingNCT05715840Phase 3
- Focal Salvage Brachytherapy Study (FocaSaBra)RecruitingNCT05715502Not applicable
- A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination TreatmentsRecruitingNCT05714839Phase 1/2
- NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast CancerRecruitingNCT05704829Phase 2
- Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare MutationsRecruitingNCT05701787
- myCare-102: Clinical Utility and Usability of Cellworks Singula™ and Cellworks Ventura™ ReportsRecruitingNCT05693831
- A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin LymphomasRecruitingNCT05685173Phase 1
- Phase 2 Multi-center Randomized Study to the Efficacy and Safety of AK105 Combined With Anrotinib Hydrochloride in Patients With Recurrent/Refractory Classical Hodgkin's LymphomaEnrolling by invitationNCT05683704Phase 2
- Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) LymphomasRecruitingNCT05681195Phase 2
- Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLCRecruitingNCT05669846Phase 2
- HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological MalignanciesRecruitingNCT05658640Phase 1/2
- Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial StudyRecruitingNCT05658081Not applicable
- CAV Regimen for R/R Ph- B-ALLRecruitingNCT05657652Not applicable
- A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) AmyloidosisRecruitingNCT05652335Phase 1
- Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change DiseaseRecruitingNCT05650619
- TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid TumorsRecruitingNCT05650580Phase 1
- CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility ProtocolRecruitingNCT05648019Phase 2
- A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic NeoplasiaRecruitingNCT05635344Phase 2
- A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft TissueRecruitingNCT05634369Phase 1/2
- Combination of CAR-DC Vaccine and ICIs in Malignant TumorsRecruitingNCT05631886Phase 1
- Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal CarcinomaRecruitingNCT05626829Phase 2
- A Compassionate Use (CU) Program of OdronextamabAvailableNCT05619367
- Study for Subjects With Relapsed/Refractory Non- Hodgkin LymphomaRecruitingNCT05618925Phase 1
- "Comparative Evaluation of 3 Dimensional Changes of Dentition in Post Orthodontic Patients With Immediate vs Delayed (Post 7 Days) Retainer DeliveryRecruitingNCT05612932Not applicable
- First in Human Study of EMB-07 in Locally Advanced/Metastatic Solid Tumors or Relapse/Refractory LymphomaRecruitingNCT05607498Phase 1
- Study Evaluating UCART20x22 in B-Cell Non-Hodgkin LymphomaRecruitingNCT05607420Phase 1/2
- A Study of ZEN003694 in People With Squamous Cell Lung CancerRecruitingNCT05607108Phase 2
- Clinical Prognostic Score to Predict Relapse in VLRecruitingNCT05602610
- Treatment Strategy for Relapsed/Refractory Hodgkin LymphomaRecruitingNCT05595447Phase 2/3
- Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MMRecruitingNCT05594797Phase 2
- 000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) MutationsRecruitingNCT05588141Phase 1/2
- Exploratory Clinical Study of CD19-targeted CAR-T and CAR-DC in the Treatment of Relapsed and Refractory B-cell LymphomaRecruitingNCT05585996Phase 1
- Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal CancersNot yet recruitingNCT05582590Phase 1
- Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/LeukemiaRecruitingNCT05576532Phase 2
- Lenvatinib Therapy in HCC Patients After LDLTRecruitingNCT05572528
- The Nordic Rectal Prolapse StudyEnrolling by invitationNCT05569980
- Safety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple MyelomaRecruitingNCT05565807Phase 1/2
- Development and Clinical Validation of Early-stage Lung Cancer Prognostic KitRecruitingNCT05557474
- Allogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHLRecruitingNCT05554939Phase 1/2
- Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic MalignanciesRecruitingNCT05544968Phase 1
- A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin LymphomaRecruitingNCT05533775Phase 1/2
- Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid TumorsRecruitingNCT05533697Phase 1/2
- Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple MyelomaRecruitingNCT05530421Phase 2
- NKG2D-CAR-NK92 Cells Immunotherapy for Solid TumorsRecruitingNCT05528341Phase 1
- Clinical Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid LeukemiaRecruitingNCT05522192Phase 1/2
- A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)RecruitingNCT05519085Phase 3
- GLS-010 Monotherapy Versus Chemotherapy in Patients With Relapsed or Refractory Classical Hodgkin's Lymphoma (R/R cHL)Not yet recruitingNCT05518318Phase 3